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2016: The Molecular Space Age
April 19: The first molecular 
biology assay in space is 
completed, as DNA is amplified 
using the miniPCR™ thermal 
cycler2
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April 29: RNA isolation, 
reverse transcription, and DNA 
amplification data obtained on 
the ISS using the Wetlab-2 
qPCR platform
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2016: The Molecular Space Age Continues
MinION™ by Oxford 
Nanopore Technologies
Biomolecule Sequencer Payload
• First attempt at DNA sequencing in the 
microgravity environment of space
• Enabled by the MinION™, developed by Oxford 
Nanopore Technologies
• COTS miniature DNA Sequencer
• 3 ¾ x 1 ¼ x 5/8 inches
• Less than 120 grams (with USB cable)
• Powered via USB connection
• Capable of DNA, RNA, and protein sequencing
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Biomolecule Sequencer: The Payload
Johnson Space Center Class 1E Payload
• ~1 year to certify a payload for flight
• Class 1E is a streamlined certification process
• Reduce the time it takes to get scientific payloads to 
the ISS and increase utilization as a National 
Laboratory 
• Authority to proceed February, 2015
• Hardware delivered on December 18, 2015
• Launched July 18, 2016 (SpaceX CRS-9)
• Technology Demonstration operations occurred on 
August 26, Sept. 3 and Sept. 7, 2016
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Biomolecule Sequencer: The Need for In-flight Sequencing
Why do we need a DNA sequencer to support 
the human exploration of space? 
• Operational environmental monitoring 
• Identification of contaminating microbes
• Infectious disease diagnosis
• Research 
• Human
• Animal
• Microbes/Cell lines
• Plant
• Med Ops
• Response to countermeasures 
• Radiation
• Functional testing for integration into robotics for 
Mars exploration missions
Clogged SRV-K line
FGB panel
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Biomolecule Sequencer: The Benefits
• Benefits to In-flight Sequencing 
• Sequencing on the ISS can inform real-time 
decisions (remediation strategies, research, med 
ops, etc.)
• Unlike other technologies, sequencing is not 
limited to the detection of specific targets, but 
rather will provide data on the entirety of a 
sample
• Reduce down mass (sample return for 
environmental monitoring, crew health, etc.)
• Real-time analysis can influence medical 
intervention
• Support astrobiology science investigations 
• Technology superiorly suited to in situ nucleic acid-
based life detection
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Biomolecule Sequencer: The Hardware
Flow Cell: Contains the nanopore
sensing technology that is required to 
perform the sequencing reaction
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Biomolecule Sequencer: Nanopore Sequencing
Nanopore-based sequencers 
measure changes in current 
caused by DNA strands 
migrating through the pore. The 
changes in current are 
characteristic of the sequence of 
migrating DNA. 
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Biomolecule Sequencer: Comparison to other Sequencers
10
Manufacturer Model Sequencing methodology
Mass-based 
cost to 
transport 
hardware to 
the ISS
Mass of 
sequencer 
hardware 
(lb)
Volume 
(cu in)
Power 
requirements
Special 
requirements
Illumina MiSeq
Fluorescence: each nucleotide 
has a different fluorophore
$1,200,000 120 6,940
100 - 240V AC, 
10A, 400 W
Illumina MiniSeq
Fluorescence: each nucleotide 
has a different fluorophore
$990,000 99 12,350 100 - 240V AC, 15A
PacBio Sequel
Fluorescence: each nucleotide 
has a different fluorophore
$7,800,000 780 81,900 208 - 240V AC, 30A
Pressurized N2 (50 
PSI)
IonTorrent Ion PGM
Electrochemical: measures 
voltage changes caused by 
nucleotide addition
$650,000 65 10,080
100 - 240V AC, 9A, 
200 - 300 W
Pressurized N2 (35 -
45 PSI)
Oxford 
Nanopore 
Technologies
MinION
Electrochemical: measures 
DNA-mediated changes in 
current passing through 
nanopores
$2,000 0.2 5
USB3 (5V, < 1A) 1 
W
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Biomolecule Sequencer: DNA Samples
Experimental Design: 
Sequence a ground-prepared sample containing a 
mixture of genomic DNA from:
• Bacteriophage lambda
• Escherichia coli
• Mouse – BALB/C (female)
Project Goals: 
1. Test the basic functionality 
by comparing ISS 
sequencing results of pre-
determined samples to 
ground results 
2. Evaluate crew operability 
and potential for degrees of 
autonomy
8. Data collection
9. Stow used 
flow cell for 
return
11. Stow MinION, 
Surface Pro3, power & 
USB cords
5. Sample injection
7. Initiate the 
sequencing experiment
2. Stowage 
(Ambient,
-90°C, + 4°C)
3. Remove flow cell and sample syringe 
from cold stowage and allow to equilibrate 
to ambient ISS temperature 
6. Dispose of 
sample syringe
12. Return of payload
4. Destow and connect MinION 
to Surface Pro3
Sequencing stops after 6 hrs
10. Data 
downlink
The First DNA Sequencer 
in Space! 1. Launch 
packaged items
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Biomolecule Sequencer: ISS Test Demo
Launch • 4 batches of libraries were prepared 
containing the genomes to be sequenced 
• From the 4 batches, 18 samples were 
produced: 9 for ISS and 9 identical 
ground controls
• Aliquots of all libraries were sequenced 
for quality control  
• Synchronous ground controls were 
performed
• 3 sequencing experiments have been 
conducted to date (Aug. 26, Sept. 3, 
Sept. 7, 2016); additional runs are 
planned 
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Biomolecule Sequencer: Results
Launch The emergence of nanopore-based sequencers greatly expands the reach of sequencing 
into low-resource field environments, enabling in situ molecular analysis. In this work, we 
evaluated the performance of the MinION DNA sequencer (Oxford Nanopore
Technologies) in-flight on the International Space Station (ISS), and benchmarked its 
performance off-Earth against the MinION, Illumina MiSeq, and PacBio RS II sequencing 
platforms in terrestrial laboratories. The samples contained mixtures of genomic DNA 
extracted from lambda bacteriophage, Escherichia coli (strain K12) and Mus musculus
(BALB/c). The in-flight sequencing experiments generated more than 80,000 total reads 
on with mean 2D accuracies of 85 to 90%, mean 1D accuracies of 75 to 80%, and median 
read lengths of approximately 6,000 bases. We were able to make directed assemblies of 
the ~4.7 Mb E. coli genome, ~48.5 kb lambda genome, and a representative M. musculus
sequence (the ~16.3 kb mitochondrial genome), at 100%, 100%, and 96.7% pairwise 
identity, and de novo assemblies of the lambda and E. coli genomes solely with yielded 
100% and 99.8% genome coverage, respectively, at 100% and 98.5% pairwise identity. 
Across all surveyed metrics (base quality, throughput, stays/base, skips/base), no 
observable decrease in MinION performance was observed while sequencing DNA in 
space. Simulated runs of in-flight nanopore data using an automated bioinformatic
pipeline demonstrated the feasibility of real-time sequencing analysis and metagenomic
identification of microbes in space. Additionally, cloud and laptop based-assembly 
illustrated the plausibility of automated, de novo genomic assembly from nanopore data 
on the ISS. Applications of sequencing for space exploration include infectious disease 
diagnosis, environmental monitoring, evaluating biological responses to spaceflight, and 
even potentially the detection of extraterrestrial life on other planetary bodies.
Did it work?   
Yes!
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(A) A mixture of equimolar DNA from mouse, E. coli and lambda phage genomes was 
sequenced in parallel on Earth (“Ground”) and in-flight on the ISS (after being 
delivered by a SpaceX Dragon capsule). Synchronous nanopore sequencing runs were 
performed from August 26 to September 13, 2016.
(B) Plot of mean current intensity in picoAmperes (pA; Y-axis) against k-mers (x-
axis) in order of increasing mean current based on a model distribution from Oxford 
Nanopore Technologies (black). Current distributions are tightly clustered with the 
exception of lower-quality ground #2.
(C) Density plots showing pairwise identity of nanopore reads collected on the ISS 
(left panel) and on the ground (right panel) relative to lambda (left box), E. coli 
(middle box) and mouse (right box) genomes. Abbreviations: 2D, high-quality two-
dimensional reads; template, 1D template read; complement, complement read. 
(D) Pie charts of the read distributions corresponding to each ISS run and pooled ISS 
runs 1 – 4, in comparison to that obtained from a ground Illumina MiSeq run of the 
same sample mixture.
Biomolecule Sequencer: Results
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(A) Flow chart of the SURPIrti
bioinformatics pipeline for real-time 
microbial detection from nanopore
data. 
(B) Donut charts of read distributions 
corresponding to all reads (left), 
viruses, (upper right), and bacteria 
(upper right) from ISS run 1. These 
charts were generated dynamically as 
part of a real-time sequencing analysis 
simulation using SURPIrt. 
Biomolecule Sequencer: 
Automated Analysis Pipeline
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(C) Stacked distributions of reads from ISS runs 1 through 
4 aligning to mouse, E. coli, and lambda. Subgroup 1 shows 
raw SURPIrt output in the absence of taxonomic 
classification, while subgroups 2 and 3 show the effects of 
classification using the GenBank NT database and separate 
viral or bacterial databases, respectively. The relative 
proportions of read counts from SURPIrt differ from those 
obtained by GraphMap alignment to the most closely 
matched reference genome in NCBI NT (subgroup 4). 
(D) Coverage (green) and pairwise identity plots (purple) of 
raw nanopore reads mapped the E. coli (upper panel), the 
mouse mitochondrial (lower left panel), and lambda 
genomes (lower left panel). Reads are mapped to the most 
closely matched reference genome identified by SURPIrt.
Biomolecule Sequencer: 
Automated Analysis Pipeline
DNA 
Extraction
DNA 
Amplification
Library 
Preparation
DNA 
Sequencing
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Looking Ahead: Need for Sample Preparation
Launch Swab to Sequencer Sample Preparation Process
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Biomolecule Sequencer: The Future
• Maintain the Biomolecule Sequencer on the ISS 
as a permanent operational and research facility.
• Continue initiatives to develop the capabilities to 
perform the sample collection and preparation 
on orbit, allowing an endless number of 
potential experiments. 
• Nanopore sequencing can go far beyond DNA 
and can enable methylation, epigenetics, RNA, 
modified bases, and protein studies.  
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Biomolecule Sequencer: Questions?
Launch 
Thank you!
David.J.Smith-3@nasa.gov
